In order to demonstrate that PDC*line cells transduced by the tumour polyepitope were able to not only activate T-cell clones, but also prime and expand naïve T-cells, we cocultured them with CD8+ T-lymphocytes purified from healthy donor PBMCs, focusing on the response against melanoma-derived antigens. This evidence concerns the gene CD8A and neoplasm.